2. Immunology/Inflammation NF-κB Apoptosis
  3. Toll-like Receptor (TLR) NF-κB TNF Receptor Interleukin Related
  4. SMU-Z1

SMU-Z1 是一种 TLR1/2 异二聚体激动剂，EC50 为 4.88 nM。SMU-Z1 可激活 NF-κB 通路，触发促炎细胞因子生成，并诱导 TNF-α、IL-1β、IL-6 及 NO 的产生。SMU-Z1 可促进脾细胞增殖，上调 CD8+T 细胞、NK 细胞和树突状细胞的表达。SMU-Z1 在小鼠白血病模型中展现出显著的抗肿瘤效果。SMU-Z1 可用于白血病的相关研究。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

SMU-Z1

SMU-Z1 Chemical Structure

CAS No. : 2410782-66-8

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

SMU-Z1 相关抗体

Top Publications Citing Use of Products

查看 Toll-like Receptor (TLR) 亚型特异性产品:

查看所有亚型
TLR3 TLR8 TLR9 TLR2 TLR4 TLR7 TLR1 TLR6

查看 NF-κB 亚型特异性产品:

查看所有亚型
NF-κB NF-κB1/p50 RelA/p65 RelB c-Rel

查看 TNF Receptor 亚型特异性产品:

查看所有亚型
TNFRSF1A/CD120a TNFRSF3/CD18 TNFRSF4 TNFRSF5/CD40 TNFRSF6/Fas/CD95 TNFRSF7/CD27 TNFRSF8/CD30 TNFRSF9/4-1BB/CD137 TNFRSF12A/TWEAK TNFRSF16/NGF Receptor/CD271 TNFRSF18/GITR/CD357

查看 Interleukin Related 亚型特异性产品:

查看所有亚型
IL-1 IL-2 IL-3 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-13 IL-15 IL-17 IL-23 IL-7 IL-33 IL-22 IL-18

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

SMU-Z1 is a TLR1/2 heterodimer agonist with an EC50 of 4.88 nM. SMU-Z1 activates the NF-κB pathway, triggers pro-inflammatory cytokine production, and induces the generation of TNF-α, IL-1β, IL-6 and NO. SMU-Z1 promotes splenocyte proliferation and upregulates the expression of CD8+T cells, NK cells and dendritic cells. SMU-Z1 exhibits significant anti-tumor effects in mouse leukemia models. SMU-Z1 can be used for leukemia-related research[1].

体外研究
(In Vitro)

SMU-Z1 可在 HEK-Blue hTLR2 细胞中特异性激活 TLR1/2 异源二聚体，其 EC50 为 4.88 × 10-9 M[1]。
SMU-Z1 (0-10 μM; 24 h) 可在 HEK-Blue hTLR2 细胞中呈剂量依赖性地稳定 TLR2 蛋白[1]。
SMU-Z1 (0-5 μM; 24 h) 可在稳定转染的人巨噬细胞 U937 中剂量依赖性激活 NF-κB 信号通路[1]。
SMU-Z1 (0-10 μM; 24 h) 可在 Raw 264.7 小鼠巨噬细胞中呈剂量依赖性地刺激 TNF-α 和 IL-1β 的产生[1]。
SMU-Z1 (0-10 μM; 24 h) 可呈剂量依赖性地刺激人外周血单个核细胞 (PBMC) 产生 TNF-α 和 IL-1β[1]。
SMU-Z1 (0-1000 nM; 24 h) 刺激 Raw 264.7 小鼠巨噬细胞产生 NO[1]。
SMU-Z1 (0-10 μM; 24 h) 上调 PBMC 中 IL-6 和 IL-8 mRNA 的表达[1]。
SMU-Z1 (0-5 μM; 24-72 h) 促进 C57Bl/6 小鼠原代脾细胞的增殖[1]。
SMU-Z1 (0-1000 nM; 48-72 h) 可呈剂量依赖性激活分离自 C57Bl/6 小鼠的初始 T 细胞增殖[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

SMU-Z1 相关抗体:

Western Blot Analysis[1]

Cell Line: HEK-Blue hTLR2 cells
Concentration: 0, 0.01, 0.1, 1, 10 μM
Incubation Time: 24 h
Result: Increased TLR2 protein stability in a dose-dependent manner, with higher TLR2 protein levels observed as concentrations increased from 0.01 to 10 μM.

ELISA Assay[1]

Cell Line: Raw 264.7 mouse leukemic monocyte macrophage cells
Concentration: 0.0007, 0.002, 0.006, 0.018, 0.036, 0.12, 0.4, 1 μM (TNF-α); 0.0015, 0.0043, 0.0133, 0.04, 0.12, 0.4, 1.2, 3.6, 10 μM (IL-1β)
Incubation Time: 24 h
Result: Stimulated dose-dependent production of TNF-α and IL-1β.
Increased TNF-α levels from ~2000 pg/mL at 0.006 μM to ~4000 pg/mL at 1 μM.
Increased IL-1β levels from ~50 pg/mL at 0.0043 μM to ~550 pg/mL at 10 μM.

Cell Proliferation Assay[1]

Cell Line: C57Bl/6 mouse primary splenocytes
Concentration: 0, 0.1, 0.5, 1, 5 μM
Incubation Time: 0, 24, 48, 72 h
Result: Dependently promoted proliferation of C57Bl/6 mouse primary splenocytes, with a 3-5-fold increase observed at 5 μM after 48 h of incubation.
体内研究
(In Vivo)

SMU-Z1 (0.3 mg；腹腔注射；每 5 天 1 次；D7-D32) 可将白血病异种移植小鼠模型的肿瘤体积降低，同时可提高脾脏及肿瘤浸润 CD8+ T 细胞、NK 细胞和 DC 细胞的频率[1]。
SMU-Z1 (0.1 mg；腹腔注射；单次) 在正常小鼠中可提升脾脏 CD8+ T 细胞频率、 CD3+CD8+TLR2+ T 细胞频率[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 (8-week-old male, 17-19 g, subcutaneous inoculation of 5 × 105 syngeneic murine FBL3 leukemia cancer cells)[1]
Dosage: 0.3 mg
Administration: i.p.; once every 5 days
Result: Reduced mean tumor volume to 386 mm3 on day 35 (vs. 2370 mm3 in PBS controls).
Induced complete tumor disappearance in 3 out of 7 treated mice after three administrations.
Increased splenic CD3+ T cells to 25.7% (vs. 11.6% in controls).
Increased splenic CD8+ T cells to 19.4% (vs. 10.6% in controls).
Increased splenic CD8/CD4 ratio to 0.28 (vs. 0.13 in controls).
Increased splenic NK cells to 10.5% (vs. 4.64% in controls).
Increased splenic DC cells to 3.87% (vs. 1.54% in controls).
Increased tumor tissue CD3+ T cells to 37.0%.
Increased tumor tissue CD8+CD3+ T cells to 28.1%.
Increased tumor tissue NK cells to 3.66%.
Increased tumor tissue DC cells to 4.12%.
Caused no significant change in mouse body weight relative to controls.
Animal Model: C57BL/6 (8-10-week-old male)[1]
Dosage: 0.1 mg
Administration: i.p.; single administration
Result: Increased splenic CD8+ T cells to 27.4% after 7 days (vs. 17.1% in PBS controls).
Increased splenic CD8+ T cells to 21.3% after 5 days (vs. 16.7% in PBS controls).
Increased splenic CD3+CD8+TLR2+ T cells to 6.3% after 5 days (vs. 2.6% in PBS controls).
Increased splenic CD3+CD8+TLR2+ T cells to 6.7% after 7 days (vs. 2.6% in PBS controls).
Reduced splenic CD4+ T cells to 55.6% (vs. 69.5% in PBS controls).
Increased the splenic CD8/CD4 ratio.
Caused no significant change in splenic CD19+ B cell frequencies.
分子量

378.31

Formula

C17H13F3N4O3
CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

SMU-Z1 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

SMU-Z12410782-66-8Toll-like Receptor (TLR)NF-κBTNF ReceptorInterleukin RelatedNuclear factor-κBNuclear factor-kappaBTumor Necrosis Factor ReceptorTNFRILIL-1βIL-6U937 human macrophage cellsTNF-αHEK-Blue hTLR2 cellsNK cellsRaw 264.7 mouse macrophage cellsTLR1/2 heterodimerNF-κB pathwayCD8+ T cellsleukemiaC57BL/6 miceInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
SMU-Z1
目录号：
HY-182644
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z